IRIS Institutional Research Information System - OPENBS Open Archive UniBS

SIGALA, SANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.434
AS - Asia 5.788
EU - Europa 4.984
SA - Sud America 937
AF - Africa 124
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 23.290
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.244
SG - Singapore 1.993
CN - Cina 1.910
IT - Italia 917
UA - Ucraina 897
BR - Brasile 762
HK - Hong Kong 646
DE - Germania 615
PL - Polonia 583
FR - Francia 478
FI - Finlandia 462
VN - Vietnam 406
GB - Regno Unito 279
RU - Federazione Russa 213
IN - India 185
TR - Turchia 185
IE - Irlanda 161
BD - Bangladesh 157
CA - Canada 109
SE - Svezia 94
JP - Giappone 60
NL - Olanda 59
BE - Belgio 57
AR - Argentina 56
ID - Indonesia 49
IQ - Iraq 43
ZA - Sudafrica 39
MX - Messico 37
CZ - Repubblica Ceca 34
EC - Ecuador 31
ES - Italia 28
PK - Pakistan 27
VE - Venezuela 20
CL - Cile 19
AT - Austria 18
CO - Colombia 17
NG - Nigeria 16
AU - Australia 15
MA - Marocco 14
UZ - Uzbekistan 13
LT - Lituania 12
EG - Egitto 11
IR - Iran 11
KE - Kenya 11
PY - Paraguay 11
SA - Arabia Saudita 11
CH - Svizzera 10
DK - Danimarca 10
CR - Costa Rica 9
EE - Estonia 9
JM - Giamaica 9
TN - Tunisia 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 7
DZ - Algeria 7
PE - Perù 7
PH - Filippine 7
AZ - Azerbaigian 6
JO - Giordania 6
KR - Corea 6
MU - Mauritius 6
UY - Uruguay 6
BO - Bolivia 5
GR - Grecia 5
IL - Israele 5
LB - Libano 5
MY - Malesia 5
NP - Nepal 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
TW - Taiwan 5
AL - Albania 4
EU - Europa 4
HN - Honduras 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NI - Nicaragua 4
RO - Romania 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
BB - Barbados 3
BH - Bahrain 3
GT - Guatemala 3
GY - Guiana 3
LV - Lettonia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
Totale 23.270
Salva come PNG Salva come JPEG
Città #
Fairfield 1.045
Singapore 1.005
Ashburn 998
Woodbridge 835
Jacksonville 652
Hong Kong 640
Warsaw 577
Houston 531
San Jose 515
Seattle 427
Cambridge 421
Dallas 389
Ann Arbor 377
Beijing 359
Wilmington 356
Chandler 331
Princeton 289
The Dalles 289
Los Angeles 283
Helsinki 276
Chicago 255
New York 255
Nanjing 227
Brescia 220
Dearborn 169
Dublin 161
Lauterbourg 156
Istanbul 148
Ho Chi Minh City 123
Des Moines 108
Nanchang 108
Munich 106
Buffalo 104
Salt Lake City 100
Council Bluffs 92
Moscow 86
Milan 78
Hanoi 76
Santa Clara 72
Shenyang 70
Secaucus 67
São Paulo 65
Shanghai 64
Turku 64
Changsha 60
Jinan 57
Brussels 56
Redondo Beach 55
San Diego 55
Tianjin 54
Orem 53
Elk Grove Village 52
Tampa 52
San Francisco 51
Dong Ket 48
Hebei 48
Pune 45
Lancaster 42
Toronto 42
West Jordan 42
London 41
Tokyo 38
Rome 37
Boardman 32
Kunming 32
Brooklyn 31
Jakarta 31
Jiaxing 31
Sterling 31
Phoenix 29
Ningbo 28
Rio de Janeiro 25
Chennai 24
Verona 24
Brno 23
Montreal 23
Zhengzhou 23
Hangzhou 22
Johannesburg 22
Frankfurt am Main 21
Guangzhou 21
Taizhou 21
Amsterdam 20
Boston 20
Haiphong 20
Nuremberg 20
Stockholm 20
Atlanta 19
Dalmine 18
Miami 18
Denver 17
Haikou 17
Poplar 17
Kyiv 16
Manchester 16
Turin 16
Abuja 15
Da Nang 15
Düsseldorf 15
Naples 15
Totale 15.305
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 790
1,25(OH)2 vitamin D(3) contributes to osteoclast-like trans-differentiation of malignant plasma cells 383
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 382
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 315
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 297
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 280
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 256
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 250
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 248
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 229
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Immunotherapy failure in adrenocortical cancer: where next? 223
I recettori muscarinici stimolano la proliferazione di leiomiociti derivati da muscolo detrusore umano 216
[Acetylcholine induces human detrusor muscle cell proliferation: molecular and pharmacological characterization.] 212
Genetic Polymorphisms as Possible Factors Involved in the Onset of Anthracycline-Induced Cardiomyopathy 211
Neoadjuvant treatment approach: The rosetta stone for breast cancer? 211
Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents 211
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 210
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 208
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 207
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 206
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 202
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 199
Should Adjuvant Weekly Paclitaxel Be Considered Less Efficacious Than Anthracyclines Plus Cyclophosphamide for Lower Risk Patients With Early-Stage Breast Cancer? 197
Abiraterone acetate exerts a cytotoxic effect in human prostate cancer cell lines 195
Amiloride Is Effective in the Management of Abiraterone-Induced Mineralocorticoid Excess Syndrome without Interfering with Its Antineoplastic Activity 193
The guanine nucleotide exchange factor VAV2 as a new prognostic parameter in adrenocortical carcinoma 190
Palbociclib inhibits proliferation of human adrenocortical tumor cells 189
Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease 189
Inhibition of Survivin Is Associated with Zoledronic Acid-induced Apoptosis of Prostate Cancer Cells 186
MUSCARINIC RECEPTORS STIMULATE CELL PROLIFERATION IN THE HUMAN UROTHELIUM-DERIVED CELL LINE UROtsa 184
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 184
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 182
Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases. 182
A new pharmacological approach to the facilitation of acetylcholine transmission. 181
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 181
Should we be cautious on the use of commercially available antibodies to dopamine receptors? 177
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 174
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 170
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 166
Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. 165
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 163
Lack of coupling of D2 receptors to adenylate cyclase in GH3 cells exposed to epidermal growth factor. Possible role of a differential expression of Gi protein subtypes 162
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 161
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 160
INVOLVEMENT OF TARGET GENE POLYMORPHISMS IN 5-FLUOROURACIL TOXICITY: A CASE REPORT 159
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 158
Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall? 156
Nerve growth factor and retinoic acid interactions in the control of small cell lung cancer proliferation. 156
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 156
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 154
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 154
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 148
The miR-21/PTEN/Akt signaling pathway is involved in the anti-tumoral effects of zoledronic acid in human breast cancer cell lines 148
Parallelism of Chemicostructural Properties between Filgrastim Originator and Three of Its Biosimilar Drugs 147
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 147
Correlation between the Overactive Bladder questionnaire (OAB-q) and urodynamic data of Parkinson disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment. 145
The role of the prostatic stroma in chronic prostatitis/chronic pelvic pain syndrome. 137
Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer 137
Different neurotransmitter systems are involved in the development of esophageal achalasia 136
Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. 136
Erratum to "Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa" [Pharmacol. Res. 64 (2011) 420-425] 135
Adrenocortical carcinoma 135
Differential gene expression of cholinergic muscarinic receptor subtypes in male and female normal human urinary bladder. 135
Nerve growth factor signaling in prostate health and disease. 134
Dopamine receptors are present in rat and human esophagus 133
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 132
Sex-related variations in serum nerve growth factor concentration in humans. 131
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 130
Detection of muscarinic receptor subtypes in human urinary bladder mucosa: Age and gender-dependent modifications 130
Clinical Outcome After Extended Endovascular Recanalization in Buerger's Disease in 20 Consecutive Cases. 129
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 129
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 128
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 126
Increased serum concentration of nerve growth factor in patients with microprolactinoma. 126
Gene expression profile of prostate cancer cell lines: Effect of nerve growth factor treatment 126
Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients 126
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 126
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 125
Selective disarrangement of the rostral telencephalic cholinergic system in heterozygous reeler mice. 123
Caffeine inhibits Direct and Indirect Angiogenesis in zebrafish embryos 122
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 122
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 122
Evidence for the presence of D1 and D2 dopamine receptors in rat oesophagus 120
I RECETTORI ADRENERGICI ALFA-1 NELL'APPARATO URINARIO UMANO: ESPRESSIONE DISTRIBUZIONE E LORO IMPLICAZIONI CLINICHE 120
Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism 119
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 119
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 118
Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment 118
Structural comparison Analysis of Erythropoietin and its biosimilars by a proteomic approach 117
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 116
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 116
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 116
ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES IN MALE AND FEMALE HUMAN URINARY BLADDER: SEX AND REGIONAL COMPARISON 116
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 112
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 111
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 111
Differential gene expression of dopamine D-2 receptor subtypes in rat chromaffin cells and sympathetic neurons in culture. 111
D-1 and D-2 dopamine receptors in rat lower esophageal sphincter: a functional study 111
FSCN1 as a new druggable target in adrenocortical carcinoma 111
Totale 17.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 104.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.255 120 185 38 68 15 58 63 76 61 152 111 308
2022/20231.060 188 62 47 79 81 258 6 87 131 14 39 68
2023/20241.391 70 39 125 99 81 250 49 66 282 70 34 226
2024/20254.142 55 46 32 522 341 246 294 109 491 248 942 816
2025/20266.949 550 864 757 917 608 391 978 312 436 668 292 176
2026/202785 85 0 0 0 0 0 0 0 0 0 0 0
Totale 23.629